As of September, there have been no new cases of the potentially fatal brain disease PML among patients taking Tysabri. The drug was pulled from the market last year after several patients taking the MS treatment developed PML. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-no-new-cases-brain-infection-biogen-drug